Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Prostate Cancer Linked to a Virus Infection

By LabMedica International staff writers
Posted on 22 Sep 2009
Cancer researchers have identified a virus in human prostate cancer cells that is strikingly similar to a type of virus known to cause leukemia and sarcomas in animals.

Investigators from the University of Utah (Salt Lake City, USA) used both quantitative polymerase chain reaction (PCR) and a specific immunoassay to screen 334 consecutive prostate resection specimens and more than 100 samples of normal prostate tissue. More...


The investigators reported in the September 8, 2009 online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) that 27% of the prostate cancer samples were infected with XMRV (xenotropic murine leukemia virus-related virus), a gamma-retrovirus similar in protein composition and particle ultrastructure to Moloney murine leukemia virus (MoMLV), another gamma-retrovirus known to cause cancer in animals.

XMRV proteins were found primarily in malignant epithelial cells, suggesting that retroviral infection may have been directly linked to development of tumors. XMRV infection was associated with prostate cancer, especially higher-grade cancers.

"We found that XMRV was present in 27% of prostate cancers we examined and that it was associated with more aggressive tumors," said senior author Dr. Ila R. Singh, associate professor of pathology at the University of Utah. "We still do not know that this virus causes cancer in people, but that is an important question we are going to investigate."

Results of earlier studies had limited XMRV infection to individuals with a mutation in the RNASEL gene. However, the current study found evidence to refute these findings, and the authors suggest that all individuals may be at risk of becoming infected. Confirmation that the virus causes prostate cancer would encourage the development of diagnostic tests, vaccines, and therapies for treating the disease.

Related Links:

University of Utah


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Radial Immunodiffusion Assay
Radial Immunodifusion - C3 ID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.